167 related articles for article (PubMed ID: 13383924)
1. [New research on the protective effect exercised by diverse sulfhydryl compounds in comparison with toxicity of nitrogen mustards and triethylene melamine].
DEYSSON G; TRUHAUT R
C R Seances Soc Biol Fil; 1956 Nov; 150(6):1171-3. PubMed ID: 13383924
[No Abstract] [Full Text] [Related]
2. Reduction of toxicity of nitrogen mustards by cysteine.
BRANDT EL; GRIFFIN AC
Cancer; 1951 Sep; 4(5):1030-5. PubMed ID: 14879371
[No Abstract] [Full Text] [Related]
3. Some effects of nitrogen mustard and triethylene melamine in acute disseminated lupus erythematosus.
ROHN RJ; BOND WH
Am J Med Sci; 1953 Aug; 226(2):179-90. PubMed ID: 13065297
[No Abstract] [Full Text] [Related]
4. [Further studies on reticuloendothelial clearance of macromolecules. V. Effect of nitrogen mustard, ethylurethane and triethylene melamine].
FRIMMER M
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 220(4):334-7. PubMed ID: 13132955
[No Abstract] [Full Text] [Related]
5. Clinical indications for the use of nitrogen mustard and triethylene melamine in malignant lymphomas and leukemias.
DIAMOND HD
Ann N Y Acad Sci; 1958 Apr; 68(3):974-8. PubMed ID: 13627744
[No Abstract] [Full Text] [Related]
6. [Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide].
SCALTRINI GC; TOGNELLA S; CONIGLIARO S; GRIFONI V
Haematol Lat; 1961; 4():411-22. PubMed ID: 14497771
[No Abstract] [Full Text] [Related]
7. Hematopoietic depression from nitrogen mustard and triethylene melamine.
MRAZEK RG; WACHOWSKI TJ
J Am Med Assoc; 1955 Sep; 159(3):160-3. PubMed ID: 13251857
[No Abstract] [Full Text] [Related]
8. Inhibition of tumour-growth after oral and parenteral treatment with nitrogen mustards and triethylene malamine.
PECZENIK O
Br J Cancer; 1952 Sep; 6(3):262-9. PubMed ID: 12987553
[No Abstract] [Full Text] [Related]
9. Comparative effects of total body radiation, nitrogen mustard, and triethylene melamine on the hematopoietic system of terminal cancer patients.
LOEFFLER RK; COLLINS VP; HYMAN GA
Science; 1953 Aug; 118(3058):161-3. PubMed ID: 13076229
[No Abstract] [Full Text] [Related]
10. NEW AND nonofficial remedies.
J Am Med Assoc; 1956 May; 161(2):150-3. PubMed ID: 13306618
[No Abstract] [Full Text] [Related]
11. [Influence of sulfonamides, nitrogen mustard, triethylene melamine and aminopterin on the blood and blood-forming organs in rabbits].
FRIEDERICI L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1955; 73(1):49-74. PubMed ID: 13262201
[No Abstract] [Full Text] [Related]
12. Changes in the urinary excretion of metabolites during treatment with nitrogen mustard and triethylenemelamine.
GERBRANDY J; HELLENDOORN HB
Br J Cancer; 1958 Sep; 12(3):458-68. PubMed ID: 13596499
[No Abstract] [Full Text] [Related]
13. Studies on the N-dealkylation of nitrogen mustard and triethylenemelamine by liver homogenates.
NADKARNI MV; TRAMS EG
Cancer Res; 1956 Dec; 16(11):1069-75. PubMed ID: 13383476
[No Abstract] [Full Text] [Related]
14. [Effect of azoyperites on circulating leukocytes].
PIZZETTI F; CLERICI E; DI PIETRO S
Tumori; 1954; 40(5):528-36. PubMed ID: 13226487
[No Abstract] [Full Text] [Related]
15. [Pharmacological and chemotherapeutic effects of radiomimetics].
SCHMIDT KH
Strahlentherapie; 1955 May; 97(1):29-45. PubMed ID: 13246868
[No Abstract] [Full Text] [Related]
16. The influence of nitrogen mustard, nitromin, and TEM on the DNA (desoxyribonucleic acid) of various kinds of tumors.
KONDO T; YAMAUCHI H; NAKAZATO H
Gan; 1955 Sep; 46(2-3):466-9. PubMed ID: 13262459
[No Abstract] [Full Text] [Related]
17. [On the protective effect of beta-aminoethyliso-thiuronium (AET) and alpha-homocysteine thiolactone (HCT) against nitrogen-lost in the mouse].
SCHUNK J
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 238():364-7. PubMed ID: 13854712
[No Abstract] [Full Text] [Related]
18. HODGKIN'S disease: diagnosis and treatment.
Med J Aust; 1953 Jun; 1(26):934-5. PubMed ID: 13070940
[No Abstract] [Full Text] [Related]
19. [Rational approach to therapy of cancer with haloalkylamines and with ethylenemelanines].
ZHDANOV GL
Biull Eksp Biol Med; 1955 Sep; 40(9):65-9. PubMed ID: 13276475
[No Abstract] [Full Text] [Related]
20. Treatment of the leukemias and lymphomas; current trends.
SYKES MP
J Am Med Womens Assoc; 1952 Sep; 7(9):321-5. PubMed ID: 12990488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
